C
Carl S. Killian
Researcher at Roswell Park Cancer Institute
Publications - 15
Citations - 1032
Carl S. Killian is an academic researcher from Roswell Park Cancer Institute. The author has contributed to research in topics: Prostate cancer & Prostate. The author has an hindex of 10, co-authored 15 publications receiving 1023 citations.
Papers
More filters
Journal Article
Quantitation of Prostate-specific Antigen in Serum by a Sensitive Enzyme Immunoassay
Manabu Kuriyama,Ming C. Wang,Lawrence D. Papsidero,Carl S. Killian,T Shimano,Luis A. Valenzuela,Tsuneo Nishiura,Gerald P. Murphy,T. M. Chu +8 more
TL;DR: Results indicate that PA is a histiotypic product of the prostate and may be of use as an adjunctive tool in diagnostic procedures of prostate cancer.
Journal Article
Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer.
Carl S. Killian,Yang N,Lawrence J. Emrich,Farida P. Vargas,Manabu Kuriyama,Ming C. Wang,Nelson H. Slack,Lawrence D. Papsidero,Gerald P. Murphy,Chu Tm +9 more
TL;DR: PA may be a useful adjuvant marker for monitoring tumor growth in patients with regionally confined prostate cancer and once a PA level of 88 ng/ml was reached, there was an average time of less than 2 months before a recurrence was clinically confirmed.
Journal Article
Use of human prostate-specific antigen in monitoring prostate cancer.
Manabu Kuriyama,Ming C. Wang,C. L. Lee,Lawrence D. Papsidero,Carl S. Killian,Hideo Inaji,Nelson H. Slack,Tsuneo Nishiura,Gerald P. Murphy,T. Ming Chu +9 more
TL;DR: It is suggested that PA is a new marker with potential value to merit further clinical study after 96 patients with advanced stage of disease and receiving chemotherapies found it to be of prognostic value with regard to the patient survival.
Journal ArticleDOI
Relative Reliability of Five Serially Measured Markers for Prognosis of Progression in Prostate Cancer
Carl S. Killian,Lawrence J. Emrich,Farida P. Vargas,Norman Yang,Ming C. Wang,Roger L. Priore,Gerald P. Murphy,T. Ming Chu +7 more
TL;DR: Elevated PA levels were predictive of increased risk 6 months before disease progression in group I patients only, and the apparent order of prognostic reliability for disease progression was found to be PA greater than PAP greater than B AP greater than AcP greater than TAP.
Journal ArticleDOI
Multiple Marker Evaluation in Human Prostate Cancer With the Use of Tissue-Specific Antigens
Manabu Kuriyama,M. C. Wang,C. L. Lee,Carl S. Killian,Papsidero Ld,H. Inaji,Rueyming Loor,M. F. Lin,T. Nishiura,N. H. Slack,Gerald P. Murphy,T.M. Chu +11 more
TL;DR: This study demonstrates that a multiple marker test of tissue-specific antigens can be of an additive value in the immunodiagnosis of cancer and may be a logical and effective approach at this time, in light of the unavailability of human tumor-specific markers.